(Q54443734)

29 May 2018

title

Adjuvant chemotherapy in postmenopausal women: results of sequential noncross-resistant regimens. (English)

1 reference

29 May 2018

author name string

C Brambilla

1

1 reference

29 May 2018

A Rossi

2

1 reference

29 May 2018

P Valagussa

3

1 reference

29 May 2018

G Bonadonna

4

1 reference

29 May 2018

publication date

1 October 1985

1 reference

29 May 2018

published in

World Journal of Surgery

1 reference

29 May 2018

volume

9

1 reference

29 May 2018

issue

5

1 reference

29 May 2018

page(s)

728-737

1 reference

29 May 2018

Response and survival in advanced breast cancer after two non-cross-resistant combinations

cites work

1 reference

12 December 2020

The methodologic dilemma in retrospectively correlating the amount of chemotherapy received in adjuvant therapy protocols with disease-free survival.

1 reference

12 December 2020

1-Phenylalanine mustard (L-PAM) in the management of primary breast cancer. A report of early findings

1 reference

12 December 2020

CONTROLLED TRIAL OF ADJUVANT CHEMOTHERAPY WITH CYCLOPHOSPHAMIDE, METHOTREXATE, AND FLUOROURACIL FOR BREAST CANCER

1 reference

12 December 2020

The importance of dose intensity in chemotherapy of metastatic breast cancer

1 reference

12 December 2020

Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples

1 reference

12 December 2020

Adjuvant systemic therapy for resectable breast cancer

1 reference

12 December 2020

CONTROLLED TRIAL OF ADJUVANT CHEMOTHERAPY WITH MELPHALAN FOR BREAST CANCER

1 reference

12 December 2020

Ten-year experience with CMF-based adjuvant chemotherapy in resectable breast cancer

1 reference

12 December 2020

Adjuvant CMFP versus CMFP plus tamoxifen versus observation alone in postmenopausal, node-positive breast cancer patients: three-year results of an Eastern Cooperative Oncology Group study

1 reference

12 December 2020

Randomized trial of 3 different regimens of combination chemotherapy in patients receiving simultaneously a hormonal treatment for advanced breast cancer

1 reference

12 December 2020

An improved criterion for the evaluation of estrogen receptor binding data in human breast cancer

1 reference

12 December 2020

Review of mortality results in randomised trials in early breast cancer

1 reference

12 December 2020

Combination Chemotherapy as an Adjuvant Treatment in Operable Breast Cancer

1 reference

12 December 2020

The CMF program for operable breast cancer with positive axillary nodes:Updated analysis on the disease-free interval, site of relapse and drug tolerance

1 reference

12 December 2020

Dose-response effect of adjuvant chemotherapy in breast cancer

1 reference

12 December 2020

Association of disease-free survival and percent of ideal dose in adjuvant breast chemotherapy.

1 reference

12 December 2020

Tumor size, sensitivity to therapy, and design of treatment schedules

1 reference

12 December 2020

Chemotherapy of disseminated breast cancer:Current status and prospects

1 reference

12 December 2020

Adjuvant chemotherapy of breast cancer: a promising experiment or standard practice?

1 reference

12 December 2020

Combination chemotherapy for metastatic breast carcinoma. Prospective comparison of multiple drug therapy with L-phenylalanine mustard

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF01655188

1 reference

29 May 2018

1 reference

29 May 2018